By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Celsis In Vitro has filed a lawsuit against Life Technologies' Invitrogen business and CellzDirect alleging infringement of a patent covering technology related to cryopreserving hepatocytes.

Celsis filed the lawsuit in US District Court for the Northern District of Illinois in Chicago on Tuesday and has moved for a preliminary injunction.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

CNBC reports that Amazon invested in the startup Grail as it sees an opportunity for its cloud computing company in genomics.

Lawrence Krauss writes at Slate that science is needed for good public policy and should not be ignored.

Researchers are working on re-making the yeast genome from scratch, according to the Associated Press.

In Cell this week: functional profiling of Plasmodium genome, a self-inactivating rabies virus, and more.